We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+5.99%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$63.9B
AUM Growth
+$3.43B
(+5.7%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
21.18%
Holding
4,866
New
886
Increased
1,406
Reduced
1,667
Closed
823
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3B |
| 2 |
Microsoft
MSFT
|
+$508M |
| 3 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$209M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$190M |
| 5 |
Qualcomm
QCOM
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$711M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 3 |
Oracle
ORCL
|
+$168M |
| 4 |
Gilead Sciences
GILD
|
+$140M |
| 5 |
Snowflake
SNOW
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.98% |
| 2 | Consumer Discretionary | 6.34% |
| 3 | Financials | 4.35% |
| 4 | Healthcare | 4.2% |
| 5 | Industrials | 3.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
Milestone Pharmaceuticals
MIST
$144M
| $82.5K | ﹤0.01% |
54,245
-439
| -0.8% | -$639 |
|
|
FARM
3902
DELISTED
Farmer Brothers
FARM
| $82.1K | ﹤0.01% |
41,465
+26,615
| +179% | +$68.3K |
|
3903
Accuray
ARAY
$28.4M
| $81.8K | ﹤0.01% |
+45,436
| New | +$86.5K |
|
3904
Sagimet Biosciences
SGMT
$437M
| $81.1K | ﹤0.01% |
29,289
-65,451
| -69% | -$202K |
|
3905
Citizens
CIA
$245M
| $81.1K | ﹤0.01% |
+22,393
| New | +$65.4K |
|
3906
CALL
Clean Energy Fuels
CLNE
$447M
| $80.9K | ﹤0.01% |
26,000
| – | – |
|
3907
OptimizeRx
OPRX
$117M
| $80.8K | ﹤0.01% |
10,460
-17,693
| -63% | -$157K |
|
3908
Village Farms International
VFF
$235M
| $80.4K | ﹤0.01% |
86,414
-111,194
| -56% | -$114K |
|
3909
Rackspace Technology
RXT
$1B
| $80.1K | ﹤0.01% |
32,708
+15,785
| +93% | +$38.1K |
|
|
ORGN
3910
DELISTED
Origin Materials
ORGN
| $79.7K | ﹤0.01% |
1,724
-1,029
| -37% | -$37.3K |
|
3911
inTEST
INTT
$173M
| $79.2K | ﹤0.01% |
10,845
-17,541
| -62% | -$146K |
|
3912
Virax Biolabs
VRAX
$2.54M
| $78.8K | ﹤0.01% |
+1,625
| New | +$93.4K |
|
|
SVC
3913
Service Properties Trust
SVC
$1.1B
| $78K | ﹤0.01% |
+3,420
| New | +$85.1K |
|
3914
Ultrapar
UGP
$6.87B
| $77.7K | ﹤0.01% |
20,028
+612
| +3% | +$2.52K |
|
3915
Aegon
AEG
$13.5B
| $77.5K | ﹤0.01% |
+12,125
| New | +$75K |
|
|
PNNT
3916
Pennant Park Investment Corp
PNNT
$215M
| $77.1K | ﹤0.01% |
+11,036
| New | +$78.7K |
|
|
ELP
3917
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $76.9K | ﹤0.01% |
+10,338
| New | +$77K |
|
3918
PUT
Nokia
NOK
$50.8B
| $76.9K | ﹤0.01% |
17,600
| – | – |
|
|
KZR
3919
DELISTED
Kezar Life Sciences
KZR
| $76.2K | ﹤0.01% |
9,850
+5,766
| +141% | +$34.8K |
|
3920
Valens Semiconductor
VLN
$176M
| $75.7K | ﹤0.01% |
34,392
-116,047
| -77% | -$275K |
|
3921
Galectin Therapeutics
GALT
$229M
| $75.4K | ﹤0.01% |
27,435
-56,639
| -67% | -$139K |
|
3922
First Majestic Silver
AG
$8.05B
| $75.3K | ﹤0.01% |
12,544
-160,767
| -93% | -$932K |
|
3923
CALL
AMC Entertainment Holdings
AMC
$2.03B
| $75.1K | ﹤0.01% |
16,500
-165,900
| -91% | -$827K |
|
3924
PUT
TMC The Metals Company
TMC
$1.59B
| $74.2K | ﹤0.01% |
70,000
-17,500
| -20% | -$19.6K |
|
|
IAUX
3925
i-80 Gold Corp
IAUX
$1.17B
| $73.5K | ﹤0.01% |
63,351
+44,082
| +229% | +$46.2K |
|
Similar funds
Squarepoint's Q3 2024 Portfolio in Review
As of Q3 2024, Squarepoint held 4,866 positions worth $63.9B, up 5.7% from $60.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Squarepoint's Q3 2024 filing shows 886 new, 1,406 increased, 1,667 reduced and 823 closed positions. Its largest new stake was State Street Real Estate Select Sector SPDR ETF: 4,950,000 shares worth $221M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $711M.
By sector, the portfolio is most concentrated in Technology at 9% of assets, down from 9.1% a quarter earlier, followed by Consumer Discretionary and Financials.
- Squarepoint's largest Q3 2024 buy was State Street Real Estate Select Sector SPDR ETF: 4,950,000 shares worth $221M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q3 2024, an estimated $3B increase.
- Squarepoint's biggest Q3 2024 reduction was Bristol-Myers Squibb, cutting an estimated $184M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q3 2024, selling an estimated $711M.
- Squarepoint's ten largest holdings make up 21% of its $63.9B portfolio in Q3 2024.
- Squarepoint opened 886 new positions and closed 823 in Q3 2024.
- Squarepoint's portfolio value rose 5.7% quarter-over-quarter to $63.9B.
Based on Squarepoint's 13F filing for Q3 2024, filed 14 Nov 2024.